Wednesday, February 25, 2009

Trubion Pharmaceuticals Chops 25

Seattle-based Trubion Pharmaceuticals announced Wednesday afternoon that the firm is cutting 25 percent of its employees, due to the "continuing uncertainty in the capital markets and the global economy." Trubion said the cuts represent 25 employees. Trubion is developing a number of biopharmaceuticals targeted at treating autoimmune and inflammatory diseases and cancer.